Clinical Trial Update: the Sequential Therapy of CD19-targeted and CD20-targeted CAR-T Cell Therapy for Diffuse Large B Cell Lymphoma(DLBCL) [Phase 1, Phase 2]

View source ↗

Summary

The study evaluates sequential administration of CD19-targeted and CD20-targeted CAR-T cell therapy in patients with diffuse large B-cell lymphoma (DLBCL) acros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CD19-targeted CAR-T cell therapy
• CD20-targeted CAR-T cell therapy (CD20-targeted chimeric antigen receptor T cells)

Snippet

Sponsor: Southwest Hospital, China | Conditions: Lymphoma, Large B-Cell, Diffuse | Phase 1, Phase 2 | Status: UNKNOWN